BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36073574)

  • 21. miR-6745-TIMP1 axis inhibits cell growth and metastasis in gastric cancer.
    Liu H; Xiang Y; Zong QB; Zhang XY; Wang ZW; Fang SQ; Zhang TC; Liao XH
    Aging (Albany NY); 2021 Nov; 13(21):24402-24416. PubMed ID: 34775375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudouridylate Synthase 7 Promotes Cell Proliferation and Invasion in Colon Cancer Through Activating PI3K/AKT/mTOR Signaling Pathway.
    Du J; Gong A; Zhao X; Wang G
    Dig Dis Sci; 2022 Apr; 67(4):1260-1270. PubMed ID: 33811565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resolving the difference between left-sided and right-sided colorectal cancer by single-cell sequencing.
    Guo W; Zhang C; Wang X; Dou D; Chen D; Li J
    JCI Insight; 2022 Jan; 7(1):. PubMed ID: 34793335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High expression of DJ-1 promotes growth and invasion via the PTEN-AKT pathway and predicts a poor prognosis in colorectal cancer.
    Lin Y; Chen Q; Liu QX; Zhou D; Lu X; Deng XF; Yang H; Zheng H; Qiu Y
    Cancer Med; 2018 Mar; 7(3):809-819. PubMed ID: 29441725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological and molecular differences between right-sided and left-sided colorectal cancer in Japanese patients.
    Natsume S; Yamaguchi T; Takao M; Iijima T; Wakaume R; Takahashi K; Matsumoto H; Nakano D; Horiguchi SI; Koizumi K; Miyaki M
    Jpn J Clin Oncol; 2018 Jul; 48(7):609-618. PubMed ID: 29767751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA SNHG6 promotes proliferation, invasion and migration in colorectal cancer cells by activating TGF-β/Smad signaling pathway via targeting UPF1 and inducing EMT via regulation of ZEB1.
    Wang X; Lai Q; He J; Li Q; Ding J; Lan Z; Gu C; Yan Q; Fang Y; Zhao X; Liu S
    Int J Med Sci; 2019; 16(1):51-59. PubMed ID: 30662328
    [No Abstract]   [Full Text] [Related]  

  • 28. Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location.
    Ben-Aharon I; Goshen-Lago T; Sternschuss M; Morgenstern S; Geva R; Beny A; Dror Y; Steiner M; Hubert A; Idelevich E; Shulman K; Mishaeli M; Man S; Liebermann N; Soussan-Gutman L; Brenner B
    Oncologist; 2019 Aug; 24(8):e696-e701. PubMed ID: 30755502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colorectal cancer liver metastases - a population-based study on incidence, management and survival.
    Engstrand J; Nilsson H; Strömberg C; Jonas E; Freedman J
    BMC Cancer; 2018 Jan; 18(1):78. PubMed ID: 29334918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
    Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
    Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive Omics Analysis of a Novel Small-Molecule Inhibitor of Chemoresistant Oncogenic Signatures in Colorectal Cancer Cell with Antitumor Effects.
    Huang TH; Mokgautsi N; Huang YJ; Wu ATH; Huang HS
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
    Guan Y; He Y; Lv S; Hou X; Li L; Song J
    J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Right or Left Primary Site of Colorectal Cancer: Outcomes From the Molecular Analysis of the AGITG MAX Trial.
    Tapia Rico G; Price T; Tebbutt N; Hardingham J; Lee C; Buizen L; Wilson K; Gebski V; Townsend A
    Clin Colorectal Cancer; 2019 Jun; 18(2):141-148. PubMed ID: 30713134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA Expression Signatures Associated With BRAF-Mutated Versus KRAS-Mutated Colorectal Cancers.
    Choi YW; Song YS; Lee H; Yi K; Kim YB; Suh KW; Lee D
    Medicine (Baltimore); 2016 Apr; 95(15):e3321. PubMed ID: 27082577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MELK Accelerates the Progression of Colorectal Cancer via Activating the FAK/Src Pathway.
    Liu G; Zhan W; Guo W; Hu F; Qin J; Li R; Liao X
    Biochem Genet; 2020 Oct; 58(5):771-782. PubMed ID: 32472210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemistry-Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal Cancer.
    Li Y; Yao Q; Zhang L; Mo S; Cai S; Huang D; Peng J
    Oncologist; 2020 Dec; 25(12):e1968-e1979. PubMed ID: 32926498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disheveled-associated activator of morphogenesis 2 promotes invasion of colorectal cancer by activating PAK1 and promoting MMP7 expression.
    Chen A; Liu Z; Wu Q; Li H
    Genes Genomics; 2021 Aug; 43(8):923-935. PubMed ID: 33974241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recent Advances on the Differences between Left- and Right-sided Colorectal Cancer].
    Zhong M; Wu B
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Dec; 43(6):980-985. PubMed ID: 34980341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic significance of the expression of monocarboxylate transporter 4 in patients with right- or left-sided colorectal cancer.
    Abe Y; Nakayama Y; Katsuki T; Inoue Y; Minagawa N; Torigoe T; Higure A; Sako T; Nagata N; Hirata K
    Asia Pac J Clin Oncol; 2019 Apr; 15(2):e49-e55. PubMed ID: 30270512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclooxygenase-2 expression in right- and left-sided colon cancer: a rationale for optimization of cyclooxygenase-2 inhibitor therapy.
    Nasir A; Kaiser HE; Boulware D; Hakam A; Zhao H; Yeatman T; Barthel J; Coppola D
    Clin Colorectal Cancer; 2004 Feb; 3(4):243-7. PubMed ID: 15025797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.